Basel, Switzerland

Sandro Nocito

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandro Nocito. Retrieved from https://idiyas.com/inventor/sandro-nocito-khpx0d1d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandro Nocito: Innovator in Pharmaceutical Compounds

Introduction

Sandro Nocito is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work has led to the filing of a patent that showcases his expertise and creativity in this domain.

Latest Patents

Sandro Nocito holds a patent for the invention titled "7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof." This patent reflects his commitment to advancing pharmaceutical science and improving therapeutic options.

Career Highlights

Nocito is currently employed at Suzhou Novartis Technical Development Co., Ltd., where he continues to push the boundaries of innovation in drug development. His role at this esteemed company allows him to collaborate with other talented professionals in the industry.

Collaborations

Some of his notable coworkers include Vincent Bordas and Jvan Brun. Their collective efforts contribute to the success of the projects they undertake, fostering an environment of innovation and excellence.

Conclusion

Sandro Nocito's contributions to the field of pharmaceuticals through his patent and work at Novartis highlight his role as a key innovator. His dedication to developing new compounds is paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…